RecruitingInterventional · Not applicableNCT04555161 ↗An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
TerminatedInterventional · Phase 2NCT04816604 ↗An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)Irina SobolPIInterventionDrug: GB002 (seralutinib) · Device: Generic Dry Powder InhalerDatesApr 2021 – Sep 2026SponsorGossamer BioPulmonary Arterial Hypertension
CompletedObservationalNCT05977933 ↗Assessing the Utility of Shape Submaximal Cardiopulmonary Exercise Testing in Detecting, Diagnosis and Treatment Management of Pulmonary Arterial Hypertension.Evelyn M. HornPIInterventionDevice: Shape II CPETDatesApr 2024 – Sep 2024 (est.)SponsorSHAPE MEDICAL SYSTEMS, INC.Pulmonary Arterial Hypertension